140 related articles for article (PubMed ID: 3383192)
1. Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro.
Tsumura M; Yoshiga K; Takada K
Cancer Res; 1988 Jul; 48(14):3977-80. PubMed ID: 3383192
[TBL] [Abstract][Full Text] [Related]
2. Effects of thermochemotherapy [1-hexylcarbamoyl-5-fluorouracil (HCFU) combined with hyperthermia]: a basic study on the most effective timing and sequence in vivo.
Sakurai K; Yoshiga K; Tsumura M; Takada K
Anticancer Res; 1996; 16(5A):2729-33. PubMed ID: 8917379
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil.
Kusumoto T; Maehara Y; Sakaguchi Y; Sugimachi K
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):477-81. PubMed ID: 2703002
[TBL] [Abstract][Full Text] [Related]
4. Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
Shiiki S; Fuchimoto S; Iwagaki H; Akazai Y; Matsubara N; Watanabe T; Orita K
Acta Med Okayama; 1991 Oct; 45(5):339-45. PubMed ID: 1836706
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermia potentiates the cytotoxic activity of 1-hexylcarbamoyl-5-fluorouracil in sarcoma-180 cells and human malignant tumor cells.
Kusumoto T; Maehara Y; Sakaguchi Y; Kohnoe S; Sugimachi K
Anticancer Res; 1991; 11(6):1963-6. PubMed ID: 1776828
[TBL] [Abstract][Full Text] [Related]
6. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
[TBL] [Abstract][Full Text] [Related]
7. [Experimental studies on the uptake of anticancer drugs in cancer cells in hyperthermochemotherapy--effects of in vitro and in vivo heating on the uptake of 5-fluorouracil in Ehrlich cells].
Yamane T
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):254-65. PubMed ID: 3713678
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
Hoshi A; Iigo M; Nakamura A; Yoshida M; Kuretani K
Gan; 1976 Oct; 67(5):725-31. PubMed ID: 1017587
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
[TBL] [Abstract][Full Text] [Related]
10. 1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro.
Maehara Y; Kusumoto H; Anai H; Kusumoto T; Hiramoto Y; Sugimachi K
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1511-5. PubMed ID: 3678315
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil.
Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y
Cancer Chemother Pharmacol; 1980; 4(2):83-7. PubMed ID: 7389060
[TBL] [Abstract][Full Text] [Related]
12. Effects of hyperthermia on the metabolism of 5-fluorouracil in vitro.
Maeta M; Sawata T; Kaibara N
Int J Hyperthermia; 1993; 9(1):105-13. PubMed ID: 8433020
[TBL] [Abstract][Full Text] [Related]
13. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil.
Nakanishi H; Abe A; Inada K; Tsukamoto T; Yasui K; Tatematsu M
J Cancer Res Clin Oncol; 1999 Dec; 125(12):660-8. PubMed ID: 10592098
[TBL] [Abstract][Full Text] [Related]
15. [Human colorectal carcinoma is more sensitive to HCFU than 5-FU and tegafur in in vitro and in vivo drug sensitivity tests].
Kusumoto T; Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):257-61. PubMed ID: 3124767
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K
Oncology; 1988; 45(3):144-7. PubMed ID: 3130595
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fate on 1-hexylcarbamoyl-5-fluorouracil and 5-fluorouracil in mice bearing ascites sarcoma 180.
Iigo M; Kuretani K; Hoshi A
J Natl Cancer Inst; 1981 Feb; 66(2):345-9. PubMed ID: 6935483
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antitumor effects of 5-fluorouracil combined with ultrasound on Ehrlich ascites tumor in vivo.
Mohamed MM; Mohamed MA; Fikry NM
Ultrasound Med Biol; 2003 Nov; 29(11):1635-43. PubMed ID: 14654158
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of metabolites of 1-hexylcarbamoyl-5-fluorouracil and related compounds against L1210 leukemia in vivo and L5178Y lymphoma cells in vitro.
Hoshi A; Yoshida M; Inomata M; Iigo M; Ando N; Kuretani K
J Pharmacobiodyn; 1980 Sep; 3(9):478-81. PubMed ID: 7463306
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
